Showing results (1771-1780 of 1,853) with videos related to
Sort By:
Pageof 186
Inflammatory Bowel Diseases|February 20, 2020
Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP ArrayDaisuke Okamoto, Yosuke Kawai, Yoichi Kakuta, et al.JCO Precision Oncology|May 11, 2022
Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal CancerHideaki Bando, Yoshiaki Nakamura, Hiroya Taniguchi, et al.Journal of Gastroenterology|September 17, 2018
Capsule endoscopy findings for the diagnosis of Crohn's disease: a nationwide case-control studyMotohiro Esaki, Takayuki Matsumoto, Naoki Ohmiya, et al.Scientific Reports|June 26, 2020
An Integrated Genomic and Transcriptomic Analysis Reveals Candidates of Susceptibility Genes for Crohn's Disease in Japanese PopulationsYoichi Kakuta, Ryo Ichikawa, Yuta Fuyuno, et al.Journal of Gastroenterology|January 26, 2024
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteriaMakoto Naganuma, Naohiro Nakamura, Reiko Kunisaki, et al.PLOS Global Public Health|November 22, 2023
Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional studySivaprakasam T Selvavinayagam, Bijulal Aswathy, Yean K Yong, et al.Nature Medicine|November 12, 2021
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trialYoshiaki Nakamura, Wataru Okamoto, Takeshi Kato, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 1, 2022
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in JapanMasahiko Aoki, Shigenori Kadowaki, Naoki Takahashi, et al.European Journal of Cancer (Oxford, England : 1990)|March 25, 2026
Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)Yosuke Kito, Kentaro Yamazaki, Hirokazu Shoji, et al.Journal of the Anus, Rectum and Colon|April 28, 2023
Clinical Guidelines for Diagnosis and Management of Juvenile Polyposis Syndrome in Children and Adults-Secondary PublicationTakayuki Matsumoto, Junji Umeno, Keisuke Jimbo, et al.Pageof 186